Adaptimmune Therapeutics plc (ADAP): Price and Financial Metrics

Adaptimmune Therapeutics plc (ADAP)

Today's Latest Price: $2.81 USD

0.04 (-1.40%)

Updated Mar 30 3:46pm

Add ADAP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 337 in Biotech

See all "A" rated Strong Buy stocks

ADAP Stock Summary

  • With a price/sales ratio of 357.78, Adaptimmune Therapeutics PLC has a higher such ratio than 99.23% of stocks in our set.
  • Revenue growth over the past 12 months for Adaptimmune Therapeutics PLC comes in at -98.11%, a number that bests merely 0.48% of the US stocks we're tracking.
  • The volatility of Adaptimmune Therapeutics PLC's share price is greater than that of 96.21% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to ADAP, based on their financial statements, market capitalization, and price volatility, are GERN, CRNX, FIXX, INO, and SNDX.
  • ADAP's SEC filings can be seen here. And to visit Adaptimmune Therapeutics PLC's official web site, go to
ADAP Daily Price Range
ADAP 52-Week Price Range

ADAP Stock Price Chart More Charts

ADAP Price/Volume Stats

Current price $2.81 52-week high $6.00
Prev. close $2.85 52-week low $0.71
Day low $2.76 Volume 170,766
Day high $2.92 Avg. volume 2,051,142
50-day MA $3.55 Dividend yield N/A
200-day MA $2.31 Market Cap 365.51M

Adaptimmune Therapeutics plc (ADAP) Company Bio

Adaptimmune Therapeutics plc is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. The company was founded in 2014 and is based in Abingdon, the United Kingdom.

ADAP Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ADAP Latest Social Stream

Loading social stream, please wait...

View Full ADAP Social Stream

ADAP Price Returns

1-mo -22.38%
3-mo 134.17%
6-mo 100.71%
1-year -34.65%
3-year -49.00%
5-year N/A
YTD 134.17%
2019 -79.13%
2018 -13.92%
2017 64.94%
2016 -66.42%
2015 N/A

Continue Researching ADAP

Here are a few links from around the web to help you further your research on Adaptimmune Therapeutics PLC's stock as an investment opportunity:

Adaptimmune Therapeutics PLC (ADAP) Stock Price | Nasdaq
Adaptimmune Therapeutics PLC (ADAP) Stock Quote, History and News - Yahoo Finance
Adaptimmune Therapeutics PLC (ADAP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0198 seconds.